OptumRx: 5 costly drugs coming this year

(By Alia Paavola for Becker’s Hospital Review)

OptumRx released a list of five new and potentially expensive treatments coming to the market in 2019 that healthcare companies should pay attention to. They’re listed below:  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.